Effects of Ursodeoxycholic Acid on Hepatobiliary Detoxification/Elimination Mechanisms and Hepatic Fatty Acid/Triglyceride Metabolism in Morbidly Obese Patients. is a NA clinical asset sponsored by Sahlgrenska University Hospital in Non-alcoholic Fatty Liver Disease, Morbid Obesity. SEO and diligence focus: Ursodeoxycholic Acid (UDCA), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.